Clinical Trial Update: A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children [Phase 2]

View source ↗

Summary

Phase 2 trial in HIV-1 infected children comparing Zidovudine plus Lamivudine to Didanosine used alone or with Zidovudine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• Lamivudine (lamivudine)
• Zidovudine (Zidovudine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED